Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maciej Bryl
Observed names:
Bryl, Maciej,
M Bryl,
M. Bryl
Institution:
Poznan University of Medical Sciences
Observed institutions:
Poznan University of Medical Sciences,
Heliodor Swiecicki Clinical Hospital,
Greater Poland Cancer Center
ORCID:
0000-0001-6873-5861
Observed ORCID:
0000-0001-6873-5861
OpenAlex ID:
A5081417134
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer
2023
·
Charles M. Rudin
, Stephen V. Liu
, et al.
·
Journal of Clinical Oncology
·
149
PDF
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC
2022
·
Gilberto de Castro
, Naiyer A. Rizvi
, et al.
·
Journal of Thoracic Oncology
·
85
PDF
SKYSCRAPER-02: Primary results of a phase III, randomized, double-blind, placebo-controlled study of atezolizumab (atezo) + carboplatin + etoposide (CE) with or without tiragolumab (tira) in patients (pts) with untreated extensive-stage small cell lung cancer (ES-SCLC).
2022
·
Charles M. Rudin
, Stephen V. Liu
, et al.
·
Journal of Clinical Oncology
·
78
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations
2017
·
Pawel Krawczyk
, Dariusz M. Kowalski
, et al.
·
Oncology Letters
·
71
PDF
PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study
2019
·
Niels Reinmuth
, Maciej Bryl
, et al.
·
BioDrugs
·
65
PDF
Abstract CT051: SKYSCRAPER-01: A phase III, randomized trial of tiragolumab (tira) + atezolizumab (atezo) versus placebo (pbo) + atezo in patients (pts) with previously-untreated PD-L1-high, locally advanced unresectable/metastatic NSCLC
2025
·
Solange Peters
, Roy Herbst
, et al.
·
Cancer Research
·
48
Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy
2023
·
Anna Grodzka
, Agnieszka Knopik-Skrocka
, et al.
·
EXCLI journal
·
48
PDF
The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients
2019
·
Adam Szpechcinski
, Mateusz Florczuk
, et al.
·
Cellular and Molecular Life Sciences
·
29
PDF
Pembrolizumab vs placebo for early-stage non‒small-cell lung cancer after resection and adjuvant therapy: Subgroup analysis of patients who received adjuvant chemotherapy in the phase 3 PEARLS/KEYNOTE-091 study.
2023
·
Kersti Oselin
, Byoung Yong Shim
, et al.
·
Journal of Clinical Oncology
·
23
PDF
Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients
2015
·
P. Krawczyk
, K. Reszka
, et al.
·
Annals of Oncology
·
23
PDF
Serum sCD25 Protein as a Predictor of Lack of Long-Term Benefits from Immunotherapy in Non-Small Cell Lung Cancer: A Pilot Study
2021
·
Anna Siemiątkowska
, Maciej Bryl
, et al.
·
Cancers
·
18
PDF
Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study
2024
·
Niels Reinmuth
, Oscar Juan-Vidal
, et al.
·
Clinical Cancer Research
·
14
The Impact of Nutritional Support on Outcomes of Lung Cancer Surgery—Narrative Review
2025
·
Alicja Werblińska
, Dominika Zielińska
, et al.
·
Journal of Clinical Medicine
·
13
PDF
Detection of EGFR mutations in liquid biopsy samples using allele-specific quantitative PCR: A comparative real-world evaluation of two popular diagnostic systems
2021
·
Adam Szpechcinski
, Maciej Bryl
, et al.
·
Advances in Medical Sciences
·
13
PDF
A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous non-small cell lung cancer (sqNSCLC) previously treated with platinum-based chemotherapy.
2018
·
Giorgio V. Scagliotti
, Igor Bondarenko
, et al.
·
Journal of Clinical Oncology
·
13
Takotsubo cardiomyopathy in a young male with lung cancer and neoplastic embolization of the coronary microcirculation.
2018
·
Waldemar Elikowski
, Małgorzata Małek-Elikowska
, et al.
·
PubMed
·
9
SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer
2026
·
Solange Peters
, Roy Herbst
, et al.
·
Journal of Clinical Oncology
·
8
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice
2024
·
Magdalena Knetki-Wróblewska
, Rafał Dziadziuszko
, et al.
·
Frontiers in Oncology
·
8
PDF
The analysis of ALK gene rearrangement by fluorescence in situ hybridisation in non-small cel lung cancer patients
2013
·
Kamila Wojas-Krawczyk
, Paweł Adam Krawczyk
, et al.
·
Współczesna Onkologia
·
8
PDF
The Detailed Analysis of Polish Patients with Non-Small Cell Lung Cancer Through Insights from Molecular Testing (POL-MOL Study)
2024
·
Dariusz M. Kowalski
, Magdalena Zaborowska-Szmit
, et al.
·
International Journal of Molecular Sciences
·
7
PDF
Influencing Factors on the Quality of Lymph Node Dissection for Stage IA Non-Small Cell Lung Cancer: A Retrospective Nationwide Cohort Study
2024
·
Piotr Gabryel
, Piotr Skrzypczak
, et al.
·
Cancers
·
7
PDF
Review Actual status of therapeutic vaccination in non-small cell lung cancer
2014
·
Katarzyna Szyszka-Barth
, Katarzyna Ramlau
, et al.
·
Współczesna Onkologia
·
7
Prehabilitation as a key component of the Enhanced Recovery After Surgery (ERAS) program in patients with lung cancer: a narrative review
2025
·
Piotr Gabryel
, Dominika Zielińska
, et al.
·
Polish Journal of Cardio-Thoracic Surgery
·
6
PDF
Normal Lung Tissue CT Density Changes after Volumetric-Arc Radiotherapy (VMAT) for Lung Cancer
2022
·
Marek Konkol
, Maciej Bryl
, et al.
·
Journal of Personalized Medicine
·
6
PDF
Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients
2018
·
Anna Grenda
, Bożena Jarosz
, et al.
·
Journal of Thoracic Disease
·
6
PDF
Show more works
View as search
Works count:
71
Citation count:
800
H-index:
13
I10-index:
15
Year
Topic
Type